Who to call at IO Biotech, Inc., and when
Fundz watches for the moments IO Biotech, Inc. starts buying, and tells you who to reach.
- An alert the day IO Biotech, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IO Biotech, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IO Biotech, Inc.. With Fundz connected, it knows.
IO Biotech, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
iobiotech.comLeadership shakeup: 3 executive changes at IO Biotech in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
The seat is still open. No replacement has been named 342 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
IO Biotech's Senior Vice President and Chief Accounting Officer, Brian Burkavage, resigned effective December 12, 2025, to pursue another opportunity, and the company stated the departure is not due to any disputes. Chief Financial Officer Amy Sullivan will also serve as principal accounting officer after his exit, a change in finance leadership that warrants monitoring.
Key Takeaways
Brian Burkavage resigned as Senior Vice President and Chief Accounting Officer effective December 12, 2025, to pursue another opportunity.
The company states the resignation is not due to any disputes with IO Biotech.
2 more takeaways
Filing Overview
What This Means
IO Biotech, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.